Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | BID | P55957 | 3/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.39 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.39 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | EP300 | Q09472 | 1/20 | 0.39 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.39 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.39 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.39 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28163513 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL27463695 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL28164157 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL28135204 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| Hydrogen Sulfide SCHEMBL28566437 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL23768448 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL29031761 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL1425613 | 0.98 | TDP1 (0.49) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| Bromide SCHEMBL28540729 | 0.96 | TDP1 (0.47) | TDP1L3MBTL1LIPGKCNH2ALOX5 | |
| SCHEMBL28182684 | 0.96 | TDP1 (0.47) | TDP1L3MBTL1LIPGKCNH2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402110-A | Method for preparing bis (imino) pyridine compound and metal organic framework material | 中国石油化工股份有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-112724168-B | Chiral pyridine derived N, B ligand, preparation method and application in iridium-catalyzed asymmetric boronation reaction | 西安交通大学 | 2021-12-28 | — | — | CN | claimed |
| CN-112724168-A | Chiral pyridine derived N, B ligand, preparation method and application in iridium-catalyzed asymmetric boronation reaction | 西安交通大学 | 2021-04-30 | — | — | CN | claimed |
| CN-107987094-B | A kind of preparation method and application of terpyridyl Zn complex | 南京邮电大学 | 2019-08-27 | — | — | CN | claimed |
| CN-108191831-A | A kind of preparation method and application of terpyridyl compounds and its metal complex | 南京邮电大学 | 2018-06-22 | — | — | CN | claimed |
| CN-107987094-A | A kind of preparation method and application of terpyridyl Zn complex | 南京邮电大学 | 2018-05-04 | — | — | CN | claimed |
| US-8309304-B2 | composition for detecting and/or characterizing a multiple-charged biomolecule comprising a charged d8 or d10 metal complex, wherein the metal complex electrostatically binds to the multiple-charged biomolecule to induce aggregation and self-assembly of the metal complex through metal-metal interactions, | THE UNIVERSITY OF HONG KONG (CN) | 2012-11-13 | — | — | US | claimed |
| EP-1817106-B1 | METHODS FOR PRODUCING A HEXADENTATE BIMETALLIC COMPLEX | CHEVRON PHILLIPS CHEMICAL CO (US) | 2012-07-11 | — | — | EP | claimed |
| US-8057989-B2 | Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes | THE UNIVERSITY OF HONG KONG (HK) | 2011-11-15 | — | — | US | claimed |
| US-7456284-B2 | Methods for producing a hexadentate bimetallic complex | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2008-11-25 | — | — | US | claimed |
| US-20080153103-A1 | Label-Free Optical Sensing and Characterization of Biomolecules by D8 or D10 Metal Complexes | UNIVERSITY OF HONG KONG, THE (HK) | 2008-06-26 | — | — | US | claimed |
| EP-1888060-A2 | NK-B INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY | A. T. Still University of Health Sciences (US) | 2008-02-20 | — | — | EP | claimed |
| CN-101102843-A | Methods for producing a hexadentate bimetallic complex | CHEVRON PHILLIPS CHEMICAL CO (US) | 2008-01-09 | — | — | CN | claimed |
| WO-2007090343-A1 | LABEL-FREE OPTICAL SENSING AND CHARACTERIZATION OF BIOMOLECULES BY d8 OR d10 METAL COMPLEXES | THE UNIVERSITY OF HONG KONG (CN) | 2007-08-16 | — | — | WO | claimed |
| US-20070190549-A1 | Label-Free Optical Sensing and Characterization of Biomolecules by D8 or D10 Metal Complexes | HONG KONG, UNIVERSITY OF, THE (CN) | 2007-08-16 | — | — | US | claimed |
| EP-1817106-A2 | METHODS FOR PRODUCING A HEXADENTATE BIMETALLIC COMPLEX | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-08-15 | — | — | EP | claimed |
| US-20060280812-A1 | Compositions and methods for the treatment of muscular dystrophy | A.T. STILL UNIVERSITY OF HEATH SCIENCES | 2006-12-14 | — | — | US | claimed |
| WO-2006127930-A2 | NK-B INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY | A. T. STILL UNIVERSITY OF HEALTH SCIENCES (US) | 2006-11-30 | — | — | WO | claimed |
| WO-2006065458-A2 | METHODS FOR PRODUCING A HEXADENTATE BIMETALLIC COMPLEX | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2006-06-22 | — | — | WO | claimed |
| US-20060128958-A1 | Methods for producing a hexadentate bimetallic complex | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2006-06-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128958-A1 | Methods for producing a hexadentate bimetallic complex | AADAT, AP3M1, AAAS | TDP1 3123/4885L3MBTL1 2246/4885LIPG 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.